Daratumumab 1800mg Hyaluronidase 30000 Units... | Tradoi
Healthcare & Medical › Pharmaceutical Products
Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution — manufactured in Srinagar, Jammu & Kashmir by Bhat Shawl Collection. Tradoi-verified manufacturer at ₹1,50,000/pieces, MOQ 1 piece.
Product Overview
Daratumumab 1800mg with Hyaluronidase 30000 Units subcutaneous solution, supplied in vials, is a CD38-Directed Antibody for Multiple Myeloma therapy, offering precise dosage and administration for specialized medical applications.
Detailed Description
This Daratumumab 1800mg solution, formulated with Hyaluronidase 30000 Units, is a CD38-Directed Antibody designed for subcutaneous administration. Each vial contains a sterile solution with a concentration of 120 mg/mL, ensuring consistent and accurate dosing. Produced with a manufacturing date of 02 2026 and an expiry date of 01 2028, this product, under the brand DARZALEX Faspro, is made in-house to stringent quality controls, identified by batch number RBS1P00. Primarily intended for healthcare institutions, oncology centers, and specialized clinics managing Multiple Myeloma, this product supports advanced therapeutic regimens. It is procured by hospital pharmacies, government health procurement agencies, and private oncology practices requiring specific antibody-based treatments. The subcutaneous route of administration offers a less invasive option for patients, streamlining clinical workflows and enhancing patient comfort in long-term care settings. As a pharmaceutical product, it adheres to the highest standards of manufacturing and quality assurance, ensuring efficacy and safety for its indicated therapeutic area. The precise formulation and packaging in vials facilitate sterile handling and accurate dispensing in clinical environments.
Product Details
| Category | Healthcare & Medical |
|---|---|
| Sub-Category | Pharmaceutical Products |
| Product Type | Injectables & Infusions |
| Price | ₹1,50,000 per piece |
| Minimum Order Quantity | 1 pieces |
| Unit | pieces |
| Country of Origin | India |
Key Features
- Active Pharmaceutical Ingredient: Daratumumab 1800mg — targets CD38 for effective Multiple Myeloma therapy.
- Excipient: Hyaluronidase 30000 Units — facilitates subcutaneous absorption, improving patient comfort and administration.
- Route of Administration: Subcutaneous — offers a less invasive and more convenient option for patients and clinicians.
- Dosage Form: Solution — ensures consistent concentration and ease of preparation for immediate use.
- Concentration: 120 mg/mL — provides precise dosing control for therapeutic applications.
- Container Type: Vial — designed for sterile storage and accurate dispensing in clinical settings.
- Therapy Area: Multiple Myeloma — specifically indicated for the treatment of this hematological malignancy.
- Form: CD38-Directed Antibody — a targeted biological therapy for specific disease pathways.
- Brand: DARZALEX Faspro — recognized brand for specialized oncology treatments.
Applications & Use Cases
- Oncology Centers: For the treatment of Multiple Myeloma patients requiring targeted antibody therapy.
- Hospital Pharmacies: Procurement for inpatient and outpatient oncology departments.
- Specialized Clinics: Administration of subcutaneous treatments for chronic conditions like Multiple Myeloma.
- Government Health Procurement: Supply to public sector hospitals and health programs for cancer care.
- Research Institutions: Use in clinical trials and advanced studies on CD38-directed therapies.
Technical Specifications
| Api Name | Daratumumab |
|---|---|
| Excipients | Hyaluronidase |
| Dosage Form | Solution |
| Concentration | 120 mg/mL |
| Container Type | Vial |
| Route Of Administration | Subcutaneous |
| Form | CD38-Directed Antibody |
| Brand | DARZALEX Faspro |
| Batch No | RBS1P00 |
| Strength | 1800mg |
| Expiry Date | 01 2028 |
| Product Name | Darzalex Faspro 1800mg inj |
| Therapy Area | Multiple Myeloma |
| Manufacturing Date | 02 2026 |
| Excipients Strength | 30000 Units |
Payment Terms
- Full Advance
About the Supplier
Bhat Shawl Collection is a verified B2B supplier based in Srinagar, Jammu & Kashmir.
- Tradoi-verified seller
Frequently Asked Questions
What is the minimum order quantity for Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution?
The minimum order quantity (MOQ) for Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution is 1 piece.
Who manufactures Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution?
Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution is manufactured by Bhat Shawl Collection, a Tradoi-verified manufacturer based in Srinagar, Jammu & Kashmir.
What are the payment terms for Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution?
Available payment terms for Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution: Full Advance.
What is the price of Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution?
Daratumumab 1800mg Hyaluronidase 30000 Units Subcutaneous Solution is priced at ₹1,50,000 per piece by Bhat Shawl Collection. Minimum order quantity is 1 piece. Pricing may vary with order volume — contact the supplier on Tradoi to confirm bulk rates.
You May Also Like
Why Choose Tradoi?
- Every supplier's phone, email and business registration certificate are verified before going live
- Talk to the supplier directly on Tradoi chat, with no middleman
- Your phone number stays private unless you choose to share it
- If an order recorded through the Tradoi Digital Handshake goes wrong, the Tradoi team helps resolve it
View full product listing on Tradoi